Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database

BACKGROUND: The role of postoperative radiotherapy (PORT) in resected stage IIIa-N2 non-small cell lung cancer (NSCLC) patients who have received adjuvant chemotherapy remains controversial. This study aimed to explore the value of PORT and determine which patients could benefit from PORT. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ran, Gong, Jun, Liao, Zhengkai, Yu, Jing, Zhang, Junhong, Xie, Conghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372214/
https://www.ncbi.nlm.nih.gov/pubmed/35966291
http://dx.doi.org/10.21037/tcr-21-2456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372214/
https://www.ncbi.nlm.nih.gov/pubmed/35966291
http://dx.doi.org/10.21037/tcr-21-2456

Ejemplares similares